Arnado, Jenevive .
HRN: 22-45-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/15/2023
CEFTRIAXONE 1G (VIAL)
12/15/2023
12/22/2023
IVT
2 Gm
Q 24h
Acute Pyelonephritis; G4P3 (3003)
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes